Losapin 50 SPM tablets treat hypertension (3 blisters x 10 tablets)

Dosage form Box of 3 blisters x 10 tablets
Specifications Losartan

Ingredient

Composition information	Content
Losartan	50mg

Uses

indications

Losapin 50 drugs are indicated in the following cases:

Treatment of hypertension.

pharmacokinetics

No data.

Before taking Losapin 50 SPM tablets treat hypertension (3 blisters x 10 tablets)

How to use

Losapin 50 drugs for oral.

Dosage

The normal starting dose is: 50mg once a day.

The starting dose of 25mg once a day is used in patients with a decreased internal volume (patients treated with diuretics) and patients with a history of liver failure.

can increase the dose to 100mg daily, drink once or twice.

Note: The above dose is for reference only. Specific dosage depends on the condition and level of progression of the disease. For a suitable dose, you need to consult a doctor or medical specialist.What to do when using overdose?

What to do when you forget 1 dose? However, if the time to relax with the next dose is too short, skip the dose and continue the calendar of the drug. Do not use double dose to compensate for missed dose.

Side Effects

Most of the undesirable effects are light and lost over time.

Common: ADR> 1/100

Cardiovascular: Hypotension

Kidney: lower blood uric acid (when taking high doses).

Cardiovascular: lower blood pressure, chest pain, cocoa A - V degree II, chest drum, sinus slow rhythm, tachycardia, face, blush. bruises, foreign bills. vibration, bone pain, muscle weakness, joint edema, muscle fibrosis. throat.

Other effects: Sweating.

Warnings

Before using the drug you need to read the instructions carefully and refer to the information below.

contraindicated

Losapin 50 drug contraindicated in the following cases:

allergies to any ingredients of the drug.

Be cautious when using

Do not overdose.

Do not share the same Losartan potassium with diuretics holding potassium. Need to monitor potassium concentration in the elderly and kidney failure.

Efficiency and safety level of Losartan Kali has not been determined in children under the age of 18.

Some elderly people may be more sensitive to Losartan so they should start with lower doses. The starting dose should be lower than the person over 75 years old.

For people with a shortage of circulating volume, hypotension may occur at the beginning of treatment. In these patients, the starting dose should be lower.

There are changes in renal function recorded in sensitive patients treated with Losartan. In people whose renal function depends on the Rennin-Anotensin or Losartan system, causing the urinary and/or nitrogen deficiency.

Should take lower doses for patients with liver impairment and patients with medium to severe renal failure.

For patients with kidney stenosis on the one side or on both sides, using metabolic inhibitors or Losartan can increase blood urea nitrogen urea or serum creatinine.

Pregnant or lactating women

During pregnancy: Using drugs directly acting on the Renin - Angiotensin system in the middle and last three months of pregnancy can cause less amniotic fluid, hypotension, anuria, face deficiency, deformed skull and death in newborn babies.

Although, the use of drugs in the first three months of pregnancy has not been related to the risk of the fetus, but after detecting pregnancy, Losartan must be stopped as soon as possible. When needed to consult a physician.

Medicinal interaction

simultaneously used with cimetidine may increase the level of losartan potassium in serum.

Concentrated with phenobarbital can reduce the level of Losartan Kali and the concentration of its active metabolites in the serum.

may slightly increase blood urea nitrogen urea, serum creatinine, serum bilirubin, or liver enzymes.

Storage

Leave a cool place, avoid light, temperature below 30⁰C.

Other drugs

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.